Company intelligence / Profile preview

Theraskin

São Paulo or other major city likely but not confirmed, São Paulo, Brazilpharmaboardroom.com ↗

Ownership: Private
Development stage: Commercial

Overview

Theraskin transitioned from branded generics to a focus on dermocosmetics and women’s health. The company develops and markets high-quality products for skin care and prevention-oriented women's health. It has a strong presence in Brazil's pharmaceutical sector with an emphasis on technology and quality[3].

Therapeutic areas: Women's HealthDermatology
Modalities: DermocosmeticsBranded Generics (historically)
Industry: Biotech

Drug pipeline

2 assets

tretinoin

Commercial

Indications: Acne vulgaris

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Theraskin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Theraskin.

Explore the full profile